10X Genomics, Inc. Stock Price, News & Analysis

Welcome to our dedicated page for 10X Genomics news (Ticker: TXG), a resource for investors and traders seeking the latest updates and insights on 10X Genomics stock.

10x Genomics, Inc. (NASDAQ: TXG) is a life science technology company focused on single cell and spatial biology, and this news page aggregates company-related announcements, research collaborations and financial updates. The company’s integrated research solutions include instruments, consumables and software that are used by academic and translational researchers and biopharmaceutical companies to study complex biological systems.

News about 10x Genomics often highlights developments in its technology platforms, such as new single cell instruments, assays and spatial workflows. Recent announcements have described launches and enhancements within the Chromium single cell portfolio, including instruments and assays designed to make high-performance single cell analysis more accessible and scalable. The company has also reported new capabilities on its Xenium spatial platform, including spatial multiomic workflows that enable simultaneous RNA and protein detection on tissue sections.

Another key theme in TXG news is large-scale research collaborations. 10x Genomics has announced partnerships with academic medical centers, cancer institutes, research consortia and nonprofit organizations to apply its single cell and spatial technologies in areas such as autoimmune disease, oncology, immuno-oncology and transplantation. These initiatives often involve generating high-resolution molecular maps of cells and tissues, linking them with clinical data and exploring potential diagnostic or clinical reporting frameworks.

Investors and researchers following TXG news will also find periodic financial results, preliminary revenue updates and participation in healthcare and investor conferences. Together, these items provide insight into the company’s product adoption, geographic reach, research impact and engagement with the broader scientific and investment communities. Users interested in 10x Genomics can use this page to review company press releases and related coverage over time.